"The
Report Acute Pain Global Clinical Trials Review, H1, 2016 provides
information on pricing, market analysis, shares, forecast, and
company profiles for key industry participants. -
MarketResearchReports.biz"
Summary
GlobalData's
clinical trial report, Acute Pain Global Clinical Trials Review, H1,
2016" provides an overview of Acute Pain clinical trials
scenario. This report provides top line data relating to the clinical
trials on Acute Pain. Report includes an overview of trial numbers
and their average enrollment in top countries conducted across the
globe. The report offers coverage of disease clinical trials by
region, country (G7 & E7), phase, trial status, end points status
and sponsor type. Report also provides prominent drugs for
in-progress trials (based on number of ongoing trials). GlobalData
Clinical Trial Reports are generated using GlobalDatas proprietary
database - Pharma eTrack Clinical trials database. Clinical trials
are collated from 80+ different clinical trial registries,
conferences, journals, news etc across the globe. Clinical trials
database undergoes periodic update by dynamic process.
The
report enhances the decision making capabilities and helps to create
an effective counter strategies to gain competitive advantage.
View
Report At : http://www.marketresearchreports.biz/analysis/724117
Scope
-
The report provides a snapshot of the global clinical trials
landscape
-
Report provides top level data related to the clinical trials by
Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor
Type and End point status
-
The report reviews top companies involved and enlists all trials
(Trial title, Phase, and Status) pertaining to the company
-
The report provides all the unaccomplished trials (Terminated,
Suspended and Withdrawn) with reason for unaccomplishment
-
The Report provides enrollment trends for the past five years
-
Report provides latest news for the past three months
Reasons
to buy
-
Assists in formulating key business strategies with regards to
investment
-
Helps in identifying prominent locations for conducting clinical
trials which saves time and cost
-
Provides top level analysis of Global Clinical Trials Market which
helps in identifying key business opportunities
-
Supports understanding of trials count and enrollment trends by
country in global therapeutics market
-
Aids in interpreting the success rates of clinical trials by
providing a comparative scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials
-
Facilitates clinical trial assessment of the indication on a global,
regional and country level
Download
Sample copy of this Report at:
http://www.marketresearchreports.biz/sample/sample/724117
Table
Of Content
Table
of Contents
Table
of Contents 2
List
of Tables 3
List
of Figures 4
Report
Guidance 5
Clinical
Trials by Region 6
Clinical
Trials and Average Enrollment by Country 7
Top
Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top
Five Countries Contributing to Clinical Trials in Europe 11
Top
Countries Contributing to Clinical Trials in North America 12
Top
Five Countries Contributing to Clinical Trials in Middle East and
Africa 13
Top
Five Countries Contributing to Clinical Trials in Central and South
America 14
Clinical
Trials by G7 Countries: Proportion of Acute Pain to Central Nervous
System Clinical Trials 15
Clinical
Trials by Phase in G7 Countries 16
Clinical
Trials in G7 Countries by Trial Status 17
Clinical
Trials by E7 Countries: Proportion of Acute Pain to Central Nervous
System Clinical Trials 18
Clinical
Trials by Phase in E7 Countries 19
Clinical
Trials in E7 Countries by Trial Status 20
Clinical
Trials by Phase 21
In
Progress Trials by Phase 22
Clinical
Trials by Trial Status 23
Clinical
Trials by End Point Status 24
Subjects
Recruited Over a Period of Time 25
Clinical
Trials by Sponsor Type 26
Prominent
Sponsors 27
Top
Companies Participating in Acute Pain Therapeutics Clinical Trials 28
Prominent
Drugs 30
Latest
Clinical Trials News on Acute Pain 31
Mar
31, 2016: OFIRMEV (Acetaminophen) Injection Health Economic Data
Presented at 41st Annual Regional Anesthesiology and Acute Pain
Medicine Meeting 31
Mar
14, 2016: AcelRx Pharmaceuticals Advances ARX-04 into Extension Phase
of Open-Label Phase 3 Emergency Room Study 31
Mar
07, 2016: AcelRx Pharmaceuticals Initiates Phase 3 Study of ARX-04 in
Patients with Post-Operative Moderate-to-Severe Acute Pain 32
Feb
25, 2016: AcelRx Pharmaceuticals Moderate-to-Severe Acute Pain
Candidate ARX-04 Shows Improved Pain Scores in ER Patients in Interim
Phase 3 Analysis 32
Feb
19, 2016: KemPharm to Present Data From Oral Human Abuse Liability
Study for Investigational Drug KP201/APAP at the 2016 AAPM Annual
Meeting 33
Feb
11, 2016: AcelRx Pharmaceuticals Presents Phase 3 Results from ARX-04
Clinical Program at JAB Burn and Wound Care Symposium 34
Jan
21, 2016: AcelRx Pharmaceuticals Announces Presentation of Phase 3
Sufentanil Sublingual 30 mcg Tablet (ARX-04) Data at the European
Congress of Ambulatory Surgery 34
Clinical
Trial Profile Snapshots 35
Appendix
279
Abbreviations
279
Definitions
279
Research
Methodology 280
Secondary
Research 280
About
GlobalData 281
Contact
Us 281
Disclaimer
281
Source
282
Follow
us on LinkedIn:
https://www.linkedin.com/company/marketresearchreports-biz
About
us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State
Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment